Prostate cancer - HealthQuill

British-Swedish pharmaceutical company AstraZeneca Plc. has discontinued its prostate cancer trial as it failed to meet the goal of the radiographic progression-free survival target in test patients.

AstraZeneca stops prostate cancer trial, Q1 revenue up 10% to $13.6b

HQ Team April 29, 2025: British-Swedish pharmaceutical company AstraZeneca Plc. has discontinued its prostate cancer trial as it failed to meet the goal.

by HealthQuill
April 29, 2025
0 Comments

Biogen Inc., a US biotechnology company, has got marketing authorisation from the European medicines regulator for its drug to treat neurodegenerative disease, amyotrophic lateral sclerosis.

Drugs Health Pharma

UK approves oral pill to treat advanced prostate cancer

HQ Team July 19, 2024: A new pill that treats hormone sensitive advance prostate cancer has been approved by the National Institute for.

by HealthQuill
July 19, 2024
0 Comments

Novartis AG will buy a US-based biotechnology company Mariana Oncology to expand its cancer portfolio for $1 billion.

Drugs Health Pharma

Novartis AG to buy Mariana Oncology for $1 billion to build RLT assets

HQ Team May 2, 2024: Novartis AG will buy a US-based biotechnology company Mariana Oncology to expand its cancer portfolio for $1 billion..

by HealthQuill
May 2, 2024
0 Comments

The jury is still out on which virus causes chronic fatigue syndrome, its diagnosis, the treatment options, and even its very terminology. Molecular biologists at the Cornell University revisited the syndrome, which is also known as myalgic encephalomyelitis (ME) and found it may be triggered by viral infections.

Drugs Health Medical

Nocturnal awakening and prostate cancer: What you need to know

Waking up in the middle of the night is called nocturnal awakening. Studies have found nearly 35% of people wake up in the.

by HealthQuill
March 4, 2024
0 Comments

A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the University of Florida.

Drugs Health Medical

Boosting cardiorespiratory fitness lowers prostate cancer risk, study finds

HQ Team February 1, 2024: Cardio exercise can play a role in lowering the incidence of prostate cancer, according to new research. The.

by HealthQuill
February 1, 2024
0 Comments

The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of the scheduled approval date.

Drugs Health Pharma

Astellas’ prostate cancer drug for metastasis-free survival gets nod

HQ Team November 18, 2023: The Food and Drug Administration (FDA) has green-lighted Astellas Pharma’s prostrate cancer drug Xtandi five weeks ahead of.